Kimberly-Clark’s fourth quarter sales of $5 billion were in line with prior year, with organic sales up 3%, driven by a 2% increase in price from ongoing revenue growth management programs and a 1% favorable product mix, with volumes in line with the prior year period and volume trends improving for the fourth consecutive quarter. Changes in foreign currency exchange rates reduced sales by approximately 2% and the divestiture of the tissue and K-C Professional business in Brazil reduced sales by approximately 1%.

In North America, organic sales increased 3% over last year, including increases of 5% in Personal Care and 3% in Consumer Tissue that were partially offset by a 3% decrease in K-C Professional.

Outside North America, organic sales were up 5% in developing and emerging (D&E) markets. Organic sales in developed markets (Australia, South Korea and Western/Central Europe) grew 1% versus prior year.

Personal Care sales of $2.6 billion increased 2% in the quarter, while organic sales increased 6%, driven by healthy contributions from price, mix and volume. Innovation, solid commercial execution and supply improvements contributed to volume growth, led by a 4% increase in North America. In 2023, Personal Care grew 1% with an organic sales increase of 5% with broad-based growth across regions.

In 2023, sales of $20.4 billion increased 1%, with organic sales up 5%, driven by approximately 6% increase in price from ongoing revenue growth management programs and 1% from favorable product mix, offset by a 2%  decrease in volume, with sequential improvements throughout the year. Changes in foreign currency exchange rates reduced sales by 3%, and the exit of its tissue and K-C Professional business in Brazil reduced sales by 1%.